Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
3 ASX healthcare shares with global earnings power
⏸️ Investing
Why you're richer than you think you are
⏸️ Investing
February 2016 Reporting Season – Week 2 Wrap Up
⏸️ Investing
Is there any value in Scentre Group Ltd and Cochlear Limited shares?
⏸️ Investing
Why these 4 shares smashed the market today
⏸️ Investing
What you need to know about today's profit season results
⏸️ Investing
Cochlear Limited shares rocket as it posts BIG profit growth
⏸️ Investing
Results preview – Can Cochlear Limited break through $100 a share
⏸️ Investing
Is there still value in Carsales.Com Ltd, Hunter Hall International Ltd, and Cochlear Limited?
⏸️ Investing
Is Cochlear Limited one of the best blue-chip shares to own?
⏸️ Investing
5 ASX shares to profit from a falling Australian dollar
⏸️ Investing
5 ASX shares to profit from a falling Australian dollar
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
